Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-74174-x, published online 14 October 2020
The Supplementary Information published with this Article contains errors.
The degree of Takashi Oka, “PhD., DMSc”, is incorrectly given as “PhD”.
In addition, the excitation wavelength measurements within the “Supplemental materials and methods” section is omitted.
The correct Supplementary Information file is linked to this correction notice.
Author information
Authors and Affiliations
Corresponding authors
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sando, Y., Matsuoka, Ki., Sumii, Y. et al. Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep 11, 6420 (2021). https://doi.org/10.1038/s41598-021-86066-9
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-021-86066-9
